INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $505 | +21.4% | 19,981 | -18.1% | 0.05% | +31.6% |
| Q1 2023 | $416 | +51.8% | 24,385 | +77.6% | 0.04% | +40.7% |
| Q4 2022 | $274 | -100.0% | 13,729 | -54.6% | 0.03% | -57.8% |
| Q3 2022 | $652,000 | +41.4% | 30,240 | +78.6% | 0.06% | +25.5% |
| Q4 2021 | $461,000 | +59.5% | 16,930 | +88.3% | 0.05% | +8.5% |
| Q3 2020 | $289,000 | +12.0% | 8,990 | -16.7% | 0.05% | +14.6% |
| Q4 2019 | $258,000 | +15.7% | 10,791 | +24.1% | 0.04% | +7.9% |
| Q2 2019 | $223,000 | +11.5% | 8,695 | +2.7% | 0.04% | +26.7% |
| Q2 2018 | $200,000 | – | 8,466 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |